Waiting period over for Chelsea-Lundbeck transaction


The waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 has expired pertaining to Lundbeck's planned acquisition of Chelsea Therapeutics (CHTP). It will acquire Chelsea for $6.44/share plus on contingent value right for up to $1.50/share for an aggregate of $658M on a fully diluted basis.

The expiration of the waiting period satisfies one of the conditions necessary for the closing of the offer and merger.

From other sites
Comments (3)
  • checkout
    , contributor
    Comment (1) | Send Message
     
    Is it good idea to sell now at $6.57 or hold through Merger and get $.6.44 and $1.50 over 3 year period ?
    9 Jun 2014, 04:40 PM Reply Like
  • berniespear
    , contributor
    Comments (251) | Send Message
     
    Hi. So why has CHTP been stuck at 6.52? I just sold at 6.55 but wondering why. Is it halted?
    25 Jun 2014, 04:43 PM Reply Like
  • KillerCAM
    , contributor
    Comments (488) | Send Message
     
    Does anybody know how the sales of Northera are doing???
    1 Jul 2015, 02:15 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs